Cue Biopharma, Inc. (CUE)
23.18
-0.80
(-3.34%)
USD |
NASDAQ |
Aug 24, 16:00
23.16
-0.02
(-0.09%)
After-Hours: 20:00
Cue Biopharma Shareholders Equity (Quarterly) : 2.31M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.31M |
| March 31, 2026 | 21.61M |
| December 31, 2025 | 26.43M |
| September 30, 2025 | 13.25M |
| June 30, 2025 | 18.16M |
| March 31, 2025 | 6.58M |
| December 31, 2024 | 17.50M |
| September 30, 2024 | 25.37M |
| June 30, 2024 | 21.62M |
| March 31, 2024 | 30.04M |
| December 31, 2023 | 37.08M |
| September 30, 2023 | 42.67M |
| June 30, 2023 | 46.00M |
| March 31, 2023 | 55.02M |
| December 31, 2022 | 65.68M |
| September 30, 2022 | 50.76M |
| June 30, 2022 | 59.76M |
| March 31, 2022 | 64.67M |
| Date | Value |
|---|---|
| December 31, 2021 | 65.49M |
| September 30, 2021 | 63.52M |
| June 30, 2021 | 72.91M |
| March 31, 2021 | 69.67M |
| December 31, 2020 | 78.91M |
| September 30, 2020 | 87.55M |
| June 30, 2020 | 80.15M |
| March 31, 2020 | 45.24M |
| December 31, 2019 | 54.58M |
| September 30, 2019 | 27.02M |
| June 30, 2019 | 20.28M |
| March 31, 2019 | 24.74M |
| December 31, 2018 | 33.97M |
| September 30, 2018 | 39.40M |
| June 30, 2018 | 49.23M |
| March 31, 2018 | 55.24M |
| December 31, 2017 | 61.61M |
| September 30, 2017 | 4.381M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Fortress Biotech, Inc. | 164.14M |
| Equillium, Inc. | 56.02M |
| Legend Biotech Corp. | 1.230B |
| Nurix Therapeutics, Inc. | 402.63M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 30.71M |
| Total Liabilities (Quarterly) | 28.40M |
| Debt to Equity Ratio | 3.813 |
| Current Ratio | 1.255 |
| Net Debt Paydown Yield | -0.20% |